Assessment and Redesign of the systems for Results Based Financing, Human Resources for Health and Pharmaceutical Systems in Zimbabwe
European Commission (EC)
Field of Expertise:
Medical Products, Technologies; Policy/Strategy/DRA; Pharmaceutical markets (shaping, assessments, studies); Health Economics and Financing; PBF/RBF/OBF (and Budget); PBF/RBF/OBF (and Budget); Medical Products, Technologies; All/Other_A; Training and Human Resource Development
Narrative description of project:
The global objective of this study was to provide an accurate analysis of the Zimbabwean health system on three critical pillars: human resources for health (HRH), pharmaceuticals, and results-based financing (RBF). These were selected as they incur the highest expenditure for the health sector in Zimbabwe and are also critical for its performance.
Review of the SADC Pharmaceutical Business Plan Operational Plan
Botswana, South Africa, Namibia, Swaziland, Lesotho, Zimbabwe, Malawi, Zambia, Mozambique, The Democratic Republic of The Congo, Seychelles, Madagascar, Mauritius, Tanzania, Angola